title: Regulation of A1 adenosine receptors by amiodarone and electrical stimulation in rat myocardial cells in vitro.
abstract: The effects of conditions that either increase or decrease heart rate on the pharmacological properties of adenosine receptors in cultured rat myocytes were examined. Levels of A1 adenosine receptors, following prolonged treatment with electrical stimulation (ES) or the antiarrhythmic drug amiodarone, were determined using radioligand binding with the specific A1 receptor antagonist [3H]1,3-dipropyl-8-cyclopentylxanthine (CPX). The effects of lowering temperature were also explored. Exposure to amiodarone for 4 days reduced the density of A1 receptors by 19% (from 24.7 +/- 0.4 to 20.09 +/- 0.3 fmol/dish) and inhibited the rate of contraction by 60% (from 188 +/- 16 to 76 +/- 30 beats/min), without changing the receptor affinity, protein content, creatine kinase (CK) activity or cell number. Electrical stimulation at 25 degrees C elevated the density of A1 adenosine receptors by 185% (from 4.1 +/- 0.4 to 11.69 +/- 2.1 fmol/dish). Four days of reduced temperature (from 37 degrees C to either 30 or 25 degrees C) lowered the density of A1 adenosine receptors by 69 or 86%, respectively (from 24.1 +/- 1.2 to 7.4 +/- 0.4 or 3.4 +/- 0.3 fmol/dish), with no significant change in the receptor affinity, activity of CK, or lactate dehydrogenase (LDH), protein content or cell number. The observed up- and down-regulation of A1 adenosine receptors in primary myocyte cultures in response to conditions that exogenously alter the rate of contraction, is indicative of the role of adenosine receptors in adaptation of heart cells to stress.
authors.affiliation: The Otto Meyerhoff Drug Receptor Center, Department of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
authors.forename: D
authors.initials: D
authors.lastname: El-Ani
authors.forename: K A
authors.initials: KA
authors.lastname: Jacobson
authors.forename: A
authors.initials: A
authors.lastname: Shainberg
mesh_terms: D000638:Amiodarone / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D002478:Cells, Cultured; D003402:Creatine Kinase / Q000378:metabolism; D004558:Electric Stimulation; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D007700:Kinetics; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D018047:Receptors, Purinergic P1 / Q000096:biosynthesis / Q000187:drug effects / Q000502:physiology*; D013696:Temperature; D013997:Time Factors; D015854:Up-Regulation; D014970:Xanthines / Q000378:metabolism
chemical_list: D018047:Receptors, Purinergic P1; D014970:Xanthines; C051360:1,3-dipropyl-8-cyclopentylxanthine; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; D000638:Amiodarone